数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

股本结构

单位:万股
公告日期 2026-07-30 2026-07-15 2026-07-30 2026-04-29 2026-02-26 2025-12-11
证券总股本 3714.39 3566.67 2775.60 2757.19 2755.68 2755.68
普通股本 3714.39 3566.67 2775.60 2757.19 2755.68 2755.68
优先股 未披露 0.29 0.29 0.29 0.29 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2026-07-27 2026-07-16 2026-06-30 2026-03-31 2025-12-31 2025-12-08
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2026-07-30 3714.39 未披露 定期报告 2026-07-27
2026-07-15 3566.67 0.29
更多>>
Common stock offered 8,094,793 shares by the company
2026-07-16
2026-07-30 2775.60 0.29
更多>>
From March 31, 2026 to June 30, 2026 Issuance of ordinary shares under employee stock purchase plan
2026-06-30
2026-04-29 2757.19 0.29
更多>>
From December 31, 2025 to March 31, 2026 Release of restricted stock units
2026-03-31
2026-02-26 2755.68 0.29
更多>>
From December 31, 2024 to December 31, 2025 Conversion of convertible notes (including accrued interest) into ordinary shares and pre-funded warrants upon the closing of the reverse recapitalization Issuance of ordinary shares and pre-funded warrants in the Pre-Closing financing Issuance of ordinary shares to former shareholders of GLYC in connection with the closing of the reverse recapitalization Issuance of ordinary shares and pre-funded warrants in private placement financing Repurchase and cancellation of restricted stock awards Early exercise of stock options Exchange of Series Seed convertible preferred stock for Series A designated non-voting convertible preferred shares upon the closing of the reverse recapitalization
2025-12-31
2025-12-11 2755.68 未披露 定期报告 2025-12-08
2025-11-06 1389.25 0.29 定期报告 2025-09-30
2025-07-31 1389.26 0.29
更多>>
From March 31, 2025 to June 30, 2025 Exchange of Series Seed convertible preferred stock for Series A non-voting convertible preferred shares upon the closing of the reverse recapitalization Conversion of convertible notes (including accrued interest) into ordinary shares and pre-funded warrants upon the closing of the reverse recapitalization Issuance of ordinary shares and pre-funded warrants in the Pre-Closing financing Issuance of ordinary shares to former shareholders of GLYC in connection with the closing of the reverse recapitalization
2025-06-30
2025-06-18 1389.26 未披露
更多>>
1-for-100 reverse stock split of Common Share
2025-06-16
2025-06-06 6450.00 未披露 定期报告 2025-06-06
2025-05-14 6453.21 未披露
更多>>
From December 31, 2024 to March 31, 2025 Vesting of restricted stock units
2025-03-31
2025-02-13 6451.39 未披露 定期报告 2025-02-07
2024-08-08 6448.40 未披露
更多>>
From March 31, 2024 to June 30, 2024 Issuance of common stock for services Exercise of options and vesting of restricted stock units
2024-06-30
2024-05-09 6446.44 未披露 定期报告 2024-05-07
2024-05-09 6445.08 未披露
更多>>
From December 31, 2023 to March 31, 2024 Issuance of common stock for services Exercise of options and vesting of restricted stock units
2024-03-31
2024-04-01 6445.04 未披露 定期报告 2024-03-15
2024-03-27 6439.37 未披露
更多>>
From December 31,2022 to December 31,2023 Issuance of common stock, net of issuance costs Issuance of common stock for services Exercise of options and vesting of restricted stock units
2023-12-31
2023-11-03 6439.33 未披露 定期报告 2023-11-01
2023-11-03 6436.88 未披露
更多>>
From June 30, 2023 to September 30, 2023 Common stock issued under stock plans
2023-09-30
2023-08-02 6431.63 未披露 定期报告 2023-07-31
2023-08-02 6431.33 未披露
更多>>
From March 31, 2023 to June 30, 2023 Common stock issued under stock plans
2023-06-30
2023-05-03 6424.57 未披露 定期报告 2023-05-01
2023-05-03 6424.52 未披露
更多>>
From December 31, 2022 to March 31, 2023 Exercise of options and vesting of restricted stock units Issuance of common stock, net of issuance costs
2023-03-31
2023-04-21 6424.52 未披露 定期报告 2023-03-24
2023-03-29 5437.78 未披露
更多>>
From December 31, 2021 to December 31, 2022 Issuance of common stock, net of issuance costs Vesting of restricted stock units
2022-12-31
2022-08-03 5242.39 未披露
更多>>
From December 31, 2021 to June 30, 2022 Vesting of restricted stock units
2022-06-30
2022-04-28 5239.24 未披露
更多>>
From December 31, 2021 to March 31, 2022 Vesting of restricted stock units
2022-03-31
2022-03-03 5231.39 未披露
更多>>
From December 31, 2020 to December 31, 2021 Issuance of common stock, net of issuance costs Exercise of options and vesting of restricted stock units
2021-12-31
2021-11-02 5173.89 未披露
更多>>
From June 30, 2021 to September 30, 2021 Exercise of options and vesting of restricted stock units
2021-09-30
2021-05-03 5153.90 未披露
更多>>
from December 31, 2020 to March 31, 2021 Issuance of common stock, net of issuance costs Exercise of options
2021-03-31
2021-04-05 5153.90 未披露 定期报告 2021-03-24
2021-03-02 5149.36 未披露 定期报告 2021-02-26
2021-03-02 4901.76 未披露
更多>>
From December 31,2019 to December 31,2020 Issuance of common stock, net of issuance costs Exercise of options and vesting of restricted stock units
2020-12-31
2020-11-06 4782.88 未披露
更多>>
From June 30, 2020 to September 30, 2020 Issuance of common stock, net of issuance costs Exercise of options and vesting of restricted stock units
2020-09-30
2020-07-31 4772.47 未披露 定期报告 2020-07-30
2020-07-31 4671.47 未披露
更多>>
From March 31, 2020 to June 30, 2020 Issuance of common stock, net of issuance costs Exercise of options
2020-06-30
2020-05-01 4358.30 未披露
更多>>
From December 31, 2019 to March 31, 2020 Exercise of options
2020-03-31
2020-02-28 4358.30 未披露 定期报告 2020-02-26
2020-02-28 4346.69 未披露
更多>>
from December 31, 2018 to December 31, 2019 Exercise of options and vesting of RSUs
2019-12-31
2019-11-07 4335.99 未披露
更多>>
from June 30, 2019 to September 30, 2019 Exercise of options
2019-09-30
2019-08-01 4319.32 未披露
更多>>
From December 31, 2018 to June 30, 2019 Exercise of options
2019-06-30
2019-05-02 4318.12 未披露 定期报告 2019-04-30
2019-05-02 4318.02 未披露
更多>>
From December 31, 2018 to March 31, 2019 Exercise of options
2019-03-31
2019-03-06 4316.90 未披露 定期报告 2019-02-28
2019-03-06 4316.08 未披露
更多>>
From December 31, 2017 to December 31, 2018 Issuance of common stock, net of issuance costs Exercise of options and warrants
2018-12-31
2018-11-02 4313.72 未披露 定期报告 2018-09-30
2018-08-09 4305.73 未披露 定期报告 2018-08-08
2018-08-09 4305.54 未披露 定期报告 2018-06-30
2018-05-03 4249.72 未披露 定期报告 2018-05-01
2018-04-13 4249.15 未披露 定期报告 2018-04-06
2018-05-03 4249.01 未披露 定期报告 2018-03-31
2018-04-13 4248.84 未披露 定期报告 2018-03-23
2018-03-06 3435.98 未披露
更多>>
from December 31, 2016 to December 31, 2017 Issuance of common stock, net of issuance costs Exercise of options
2017-12-31
2017-11-08 3433.78 未披露 定期报告 2017-11-07
2017-11-08 3273.78 未披露 定期报告 2017-09-30
2017-08-03 3272.30 未披露 定期报告 2017-08-02
2017-08-03 3271.64 未披露 定期报告 2017-06-30
2017-05-08 2464.04 未披露 定期报告 2017-05-03
2017-05-08 2385.59 未披露 定期报告 2017-03-31
2017-03-01 2332.99 未披露 定期报告 2017-02-27
2017-03-01 2325.00 未披露
更多>>
From December 31, 2015 to December 31, 2016 Issuance of common stock, net of issuance costs Exercise of options and warrants
2016-12-31
2016-11-04 2306.51 未披露 定期报告 2016-11-03
2016-11-04 2306.34 未披露 定期报告 2016-09-30
2016-08-04 2305.63 未披露 定期报告 2016-08-03
2016-08-04 2303.04 未披露
更多>>
In June 2016, the Company completed a public offering in which the Company sold 3,476,793 shares of its common stock at a price of $6.10 per share.
2016-06-30
2016-05-04 1935.03 未披露 定期报告 2016-05-02
2016-05-04 1928.07 未披露 定期报告 2016-03-31
2016-02-29 1906.44 未披露 定期报告 2016-02-25
2016-02-29 1905.02 未披露
更多>>
from December 31, 2014 to December 31, 2015 Exercise of options and warrants
2015-12-31
2015-11-12 1903.82 未披露 定期报告 2015-11-10
2015-11-05 1141.17 未披露
更多>>
from December 31, 2014 to August 21, 2015 Conversion of convertible notes - related parties to Series F convertible preferred stock Issuance of series F convertible preferred stock, net of issuance costs of $96 Conversion of preferred stock to common stock in connection with merger Stock options exercised for cash Issuance of common stock in connection with reverse merger Common stock withheld and cancelled Conversion of redeemable convertible notes to common stock All 2015 share and per share disclosures have been adjusted to reflect the exchange of shares in the Merger, and the 7-for-1 reverse stock split of the common stock on August 20, 2015.
2015-08-21
2015-07-31 3391.59 未披露 定期报告 2015-06-30
2015-06-15 1901.71 未披露 定期报告 2015-06-12
2015-05-07 3387.23 未披露 定期报告 2015-03-31
2015-03-16 1899.48 未披露 定期报告 2015-03-10
2015-03-16 3379.37 未披露
更多>>
From December 31,2013 to December 31,2014 Issuance of common stock related to exercise of stock options
2014-12-31
2014-10-31 1889.47 未披露 定期报告 2014-10-29
2014-08-07 3379.37 未披露 定期报告 2014-06-30
2014-05-09 1879.35 未披露 定期报告 2014-05-08
2014-03-31 1860.65 未披露
更多>>
Upon closing of the Company’s initial public offering, all outstanding shares of convertible preferred stock converted into an aggregate of 9,305,359 shares of common stock.
2014-03-24
2014-01-10 1755.55 未披露
更多>>
a 1-for-3.302 reverse stock split of our common stock effected on October 25, 2013;the conversion of all outstanding shares of our convertible preferred stock into an aggregate of 9,305,359 shares of our common stock, which will occur automatically upon the completion of this offering
2014-01-10
2014-03-14 3371.82 未披露
更多>>
From December 31,2012 to December 31,2013 Issuance of common stock related to exercise of stock options
2013-12-31
2014-03-31 142.75 3072.63
更多>>
from December 31,2012 to December 31,2013 Exercise of options
2013-12-31
2013-12-20 125.01 3072.63
更多>>
from December 31, 2012 to October 28, 2013 Exercise of options In connection with preparing for the initial public offering of the Company’s common stock, the Company’s board of directors and stockholders approved a 1-for-3.302 reverse stock split of the Company’s common stock. The reverse stock split became effective on October 25, 2013.
2013-10-28
2013-11-06 3365.84 未披露 定期报告 2013-09-30
2013-08-07 3363.70 未披露 定期报告 2013-06-30
2013-10-04 312.77 3072.63
更多>>
from December 31, 2012 to June 30, 2013 Exercise of options
2013-06-30
2013-03-15 3361.51 未披露
更多>>
from December 31, 2011 to December 31, 2012 Issuance of common stock related to exercise of stock options
2012-12-31
2012-11-08 3360.63 未披露 定期报告 2012-09-30
2012-08-09 3342.86 未披露 定期报告 2012-06-30
2012-05-09 3339.78 未披露 定期报告 2012-03-31
2012-03-06 3338.34 未披露
更多>>
from December 31, 2010 to December 31, 2011 Issuance of common stock related to exercise of stock options Net proceeds from public stock offering
2011-12-31
2011-11-03 3337.85 未披露 定期报告 2011-09-30
2011-08-09 3337.21 未披露 定期报告 2011-06-30
2011-05-09 2906.13 未披露 定期报告 2011-03-31
2011-03-11 2887.07 未披露
更多>>
from December 31, 2009 to December 31, 2010 Issuance of common stock related to exercise of stock options
2010-12-31
2010-11-05 2863.60 未披露 定期报告 2010-09-30
2010-08-09 2860.05 未披露 定期报告 2010-06-30
Common stock offered 8,094,793 shares by the company
From March 31, 2026 to June 30, 2026 Issuance of ordinary shares under employee stock purchase plan
From December 31, 2025 to March 31, 2026 Release of restricted stock units
From December 31, 2024 to December 31, 2025 Conversion of convertible notes (including accrued interest) into ordinary shares and pre-funded warrants upon the closing of the reverse recapitalization Issuance of ordinary shares and pre-funded warrants in the Pre-Closing financing Issuance of ordinary shares to former shareholders of GLYC in connection with the closing of the reverse recapitalization Issuance of ordinary shares and pre-funded warrants in private placement financing Repurchase and cancellation of restricted stock awards Early exercise of stock options Exchange of Series Seed convertible preferred stock for Series A designated non-voting convertible preferred shares upon the closing of the reverse recapitalization
From March 31, 2025 to June 30, 2025 Exchange of Series Seed convertible preferred stock for Series A non-voting convertible preferred shares upon the closing of the reverse recapitalization Conversion of convertible notes (including accrued interest) into ordinary shares and pre-funded warrants upon the closing of the reverse recapitalization Issuance of ordinary shares and pre-funded warrants in the Pre-Closing financing Issuance of ordinary shares to former shareholders of GLYC in connection with the closing of the reverse recapitalization
1-for-100 reverse stock split of Common Share
From December 31, 2024 to March 31, 2025 Vesting of restricted stock units
From March 31, 2024 to June 30, 2024 Issuance of common stock for services Exercise of options and vesting of restricted stock units
From December 31, 2023 to March 31, 2024 Issuance of common stock for services Exercise of options and vesting of restricted stock units
From December 31,2022 to December 31,2023 Issuance of common stock, net of issuance costs Issuance of common stock for services Exercise of options and vesting of restricted stock units
From June 30, 2023 to September 30, 2023 Common stock issued under stock plans
From March 31, 2023 to June 30, 2023 Common stock issued under stock plans
From December 31, 2022 to March 31, 2023 Exercise of options and vesting of restricted stock units Issuance of common stock, net of issuance costs
From December 31, 2021 to December 31, 2022 Issuance of common stock, net of issuance costs Vesting of restricted stock units
From December 31, 2021 to June 30, 2022 Vesting of restricted stock units
From December 31, 2021 to March 31, 2022 Vesting of restricted stock units
From December 31, 2020 to December 31, 2021 Issuance of common stock, net of issuance costs Exercise of options and vesting of restricted stock units
From June 30, 2021 to September 30, 2021 Exercise of options and vesting of restricted stock units
from December 31, 2020 to March 31, 2021 Issuance of common stock, net of issuance costs Exercise of options
From December 31,2019 to December 31,2020 Issuance of common stock, net of issuance costs Exercise of options and vesting of restricted stock units
From June 30, 2020 to September 30, 2020 Issuance of common stock, net of issuance costs Exercise of options and vesting of restricted stock units
From March 31, 2020 to June 30, 2020 Issuance of common stock, net of issuance costs Exercise of options
From December 31, 2019 to March 31, 2020 Exercise of options
from December 31, 2018 to December 31, 2019 Exercise of options and vesting of RSUs
from June 30, 2019 to September 30, 2019 Exercise of options
From December 31, 2018 to June 30, 2019 Exercise of options
From December 31, 2018 to March 31, 2019 Exercise of options
From December 31, 2017 to December 31, 2018 Issuance of common stock, net of issuance costs Exercise of options and warrants
from December 31, 2016 to December 31, 2017 Issuance of common stock, net of issuance costs Exercise of options
From December 31, 2015 to December 31, 2016 Issuance of common stock, net of issuance costs Exercise of options and warrants
In June 2016, the Company completed a public offering in which the Company sold 3,476,793 shares of its common stock at a price of $6.10 per share.
from December 31, 2014 to December 31, 2015 Exercise of options and warrants
from December 31, 2014 to August 21, 2015 Conversion of convertible notes - related parties to Series F convertible preferred stock Issuance of series F convertible preferred stock, net of issuance costs of $96 Conversion of preferred stock to common stock in connection with merger Stock options exercised for cash Issuance of common stock in connection with reverse merger Common stock withheld and cancelled Conversion of redeemable convertible notes to common stock All 2015 share and per share disclosures have been adjusted to reflect the exchange of shares in the Merger, and the 7-for-1 reverse stock split of the common stock on August 20, 2015.
From December 31,2013 to December 31,2014 Issuance of common stock related to exercise of stock options
Upon closing of the Company’s initial public offering, all outstanding shares of convertible preferred stock converted into an aggregate of 9,305,359 shares of common stock.
a 1-for-3.302 reverse stock split of our common stock effected on October 25, 2013;the conversion of all outstanding shares of our convertible preferred stock into an aggregate of 9,305,359 shares of our common stock, which will occur automatically upon the completion of this offering
From December 31,2012 to December 31,2013 Issuance of common stock related to exercise of stock options
from December 31,2012 to December 31,2013 Exercise of options
from December 31, 2012 to October 28, 2013 Exercise of options In connection with preparing for the initial public offering of the Company’s common stock, the Company’s board of directors and stockholders approved a 1-for-3.302 reverse stock split of the Company’s common stock. The reverse stock split became effective on October 25, 2013.
from December 31, 2012 to June 30, 2013 Exercise of options
from December 31, 2011 to December 31, 2012 Issuance of common stock related to exercise of stock options
from December 31, 2010 to December 31, 2011 Issuance of common stock related to exercise of stock options Net proceeds from public stock offering
from December 31, 2009 to December 31, 2010 Issuance of common stock related to exercise of stock options